HERRERA, Fabian. LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT. Mediterranean Journal of Hematology and Infectious Diseases, [S. l.], v. 16, n. 1, p. e2024039, 2024. DOI: 10.4084/MJHID.2024.039. Disponível em: https://www.mjhid.org/mjhid/article/view/5613. Acesso em: 3 jul. 2024.